Truvestments Capital’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3K | Hold |
250
| – | – | 0.01% | 436 |
|
|
2025
Q1 | $39.3K | Hold |
250
| – | – | 0.01% | 442 |
|
|
2024
Q4 | $39.2K | Hold |
250
| – | – | 0.01% | 409 |
|
|
2024
Q3 | $44.3K | Buy |
+250
| New | +$44.3K | 0.01% | 372 |
|
|
2024
Q2 | – | Sell |
-250
| Closed | -$41.6K | – | 269 |
|
|
2024
Q1 | $41.6K | Hold |
250
| – | – | 0.02% | 369 |
|
|
2023
Q4 | $41.3K | Hold |
250
| – | – | 0.02% | 344 |
|
|
2023
Q3 | $38.9K | Hold |
250
| – | – | 0.02% | 307 |
|
|
2023
Q2 | $39K | Hold |
250
| – | – | 0.02% | 313 |
|
|
2023
Q1 | $40.5K | Hold |
250
| – | – | 0.02% | 307 |
|
|
2022
Q4 | $39.9K | Hold |
250
| – | – | 0.02% | 320 |
|
|
2022
Q3 | $35K | Hold |
250
| – | – | 0.02% | 288 |
|
|
2022
Q2 | $36K | Buy |
+250
| New | +$36K | 0.02% | 288 |
|
|
2022
Q1 | – | Sell |
-250
| Closed | -$47K | – | 217 |
|
|
2021
Q4 | $47K | Hold |
250
| – | – | 0.02% | 274 |
|
|
2021
Q3 | $51K | Hold |
250
| – | – | 0.03% | 249 |
|
|
2021
Q2 | $50K | Sell |
250
-25
| -9% | -$5K | 0.03% | 249 |
|
|
2021
Q1 | $48K | Hold |
275
| – | – | 0.03% | 283 |
|
|
2020
Q4 | $46K | Buy |
+275
| New | +$46K | 0.03% | 271 |
|
|
2020
Q3 | – | Sell |
-275
| Closed | -$44K | – | 345 |
|
|
2020
Q2 | $44K | Buy |
+275
| New | +$44K | 0.04% | 219 |
|
|
2019
Q4 | – | Sell |
-275
| Closed | -$32K | – | 182 |
|
|
2019
Q3 | $32K | Hold |
275
| – | – | 0.02% | 323 |
|
|
2019
Q2 | $35K | Buy |
+275
| New | +$35K | 0.02% | 331 |
|